UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 135

Sortiert nach

Favipiravir (T-705), a novel viral RNA polymerase inhibitor

Antiviral research, 2013-11, Vol.100 (2), p.446-454

2013

Volltextzugriff (PDF)

Animal models for the study of influenza pathogenesis and therapy

Antiviral research, 2009-05, Vol.82 (2), p.A110-A122

Barnard, Dale L.

2009

Volltextzugriff (PDF)

Protease inhibitors targeting coronavirus and filovirus entry

Antiviral research, 2015-04, Vol.116, p.76-84

2015

Volltextzugriff (PDF)

Inducible bronchus-associated lymphoid tissue elicited by a protein cage nanoparticle enhances protection in mice against diverse respiratory viruses

PloS one, 2009-09, Vol.4 (9), p.e7142

2009

Volltextzugriff (PDF)

Current status of anti-picornavirus therapies

Current pharmaceutical design, 2006-04, Vol.12 (11), p.1379

Barnard, Dale L

2006

Volltextzugriff (PDF)

Prophylactic and therapeutic intranasal administration with an immunomodulator, Hiltonol® (Poly IC:LC), in a lethal SARS-CoV-infected BALB/c mouse model

Antiviral research, 2017-03, Vol.139, p.1-12

2017

Volltextzugriff (PDF)

Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A viruses

PloS one, 2012-01, Vol.7 (1), p.e31006

2012

Volltextzugriff (PDF)

Broad-Spectrum In Vitro Activity and In Vivo Efficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the Family Coronaviridae

Journal of Virology, 2010-03, Vol.84 (5), p.2511-2521

2010

Volltextzugriff (PDF)

Activities of JNJ63623872 and oseltamivir against influenza A H1N1pdm and H3N2 virus infections in mice

Antiviral research, 2016-12, Vol.136, p.45-50

2016

Volltextzugriff (PDF)

A broadly neutralizing human monoclonal antibody is effective against H7N9

Proceedings of the National Academy of Sciences - PNAS, 2015-09, Vol.112 (35), p.10890-10895

2015

Volltextzugriff (PDF)

T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections

Antiviral research, 2009-06, Vol.82 (3), p.95-102

2009

Volltextzugriff (PDF)

Targeting Robo4-dependent Slit signaling to survive the cytokine storm in sepsis and influenza

Science translational medicine, 2010-03, Vol.2 (23), p.23ra19

2010

Volltextzugriff (PDF)

New Small Molecule Entry Inhibitors Targeting Hemagglutinin-Mediated Influenza A Virus Fusion

Journal of Virology, 2014-02, Vol.88 (3), p.1447-1460

2014

Volltextzugriff (PDF)

The Iminosugar UV-4 is a Broad Inhibitor of Influenza A and B Viruses ex Vivo and in Mice

Viruses, 2016-03, Vol.8 (3), p.71-71

2016

Volltextzugriff (PDF)

A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo

Virology (New York, N.Y.), 2009-12, Vol.395 (2), p.210-222

2009

Volltextzugriff (PDF)

Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV

Vaccine, 2011-09, Vol.29 (38), p.6606-6613

2011

Volltextzugriff (PDF)

Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapy

Future Virology, 2011-05, Vol.6 (5), p.615-631

2011

Volltextzugriff (PDF)

Lack of selective resistance of influenza A virus in presence of host-targeted antiviral, UV-4B

Scientific reports, 2019-05, Vol.9 (1), p.7484-7484, Article 7484

2019

Volltextzugriff (PDF)

Efficacy of Orally Administered T-705 on Lethal Avian Influenza A (H5N1) Virus Infections in Mice

Antimicrobial Agents and Chemotherapy, 2007-03, Vol.51 (3), p.845-851

2007

Volltextzugriff (PDF)

Serum amyloid A (SAA) is an early biomarker of influenza virus disease in BALB/c, C57BL/2, Swiss-Webster, and DBA.2 mice

Antiviral research, 2016-09, Vol.133, p.196-207

2016

Volltextzugriff (PDF)

In vitro activity of favipiravir and neuraminidase inhibitor combinations against oseltamivir-sensitive and oseltamivir-resistant pandemic influenza A (H1N1) virus

Archives of virology, 2014-06, Vol.159 (6), p.1279-1291

2014

Volltextzugriff (PDF)

Identification of phenanthroindolizines and phenanthroquinolizidines as novel potent anti-coronaviral agents for porcine enteropathogenic coronavirus transmissible gastroenteritis virus and human severe acute respiratory syndrome coronavirus

Antiviral research, 2010-11, Vol.88 (2), p.160-168

2010

Volltextzugriff (PDF)

Design, Synthesis and Antiviral Activity of 2-(3-Amino-4-piperazinylphenyl)chromone Derivatives

Chemical and Pharmaceutical Bulletin, 2013/04/01, Vol.61(4), pp.486-488

2013

Volltextzugriff (PDF)

Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin

Antiviral research, 2011-04, Vol.90 (1), p.22-32

2011

Volltextzugriff (PDF)

Examining the interactions of Galahad™ compound with viruses to develop a novel inactivated influenza A virus vaccine

Heliyon, 2022-07, Vol.8 (7), p.e09887-e09887, Article e09887

2022

Volltextzugriff (PDF)

1 – 25 von 135

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(121)
Mit Volltextzugriff
(111)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(135)
Japanisch
(23)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(90)
Life Sciences & Biomedicine
(72)
Animals
(62)
Humans
(46)
Antiviral Agents
(43)
Biological And Medical Sciences
(43)
Pharmacology & Pharmacy
(41)
Antiviral Agents - Pharmacology
(40)
Virology
(39)
Medical Sciences
(37)
Pharmacology. Drug Treatments
(37)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(36)
Mice
(36)
Female
(28)
Mice, Inbred Balb C
(24)
Cell Line
(20)
Sars Coronavirus
(19)
Antiviral Agents - Therapeutic Use
(18)
Influenza
(18)
Antiviral
(17)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Favipiravir (T-705), a novel viral RNA polymerase inhibitor

Animal models for the study of influenza pathogenesis and therapy

Protease inhibitors targeting coronavirus and filovirus entry

Inducible bronchus-associated lymphoid tissue elicited by a protein cage nanoparticle enhances protection in mice against diverse respiratory viruses

Current status of anti-picornavirus therapies

Prophylactic and therapeutic intranasal administration with an immunomodulator, Hiltonol® (Poly IC:LC), in a lethal SARS-CoV-infected BALB/c mouse model

Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A viruses

Broad-Spectrum In Vitro Activity and In Vivo Efficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the Family Coronaviridae

Activities of JNJ63623872 and oseltamivir against influenza A H1N1pdm and H3N2 virus infections in mice

A broadly neutralizing human monoclonal antibody is effective against H7N9

T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections

Targeting Robo4-dependent Slit signaling to survive the cytokine storm in sepsis and influenza

New Small Molecule Entry Inhibitors Targeting Hemagglutinin-Mediated Influenza A Virus Fusion

The Iminosugar UV-4 is a Broad Inhibitor of Influenza A and B Viruses ex Vivo and in Mice

A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo

Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV

Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapy

Lack of selective resistance of influenza A virus in presence of host-targeted antiviral, UV-4B

Efficacy of Orally Administered T-705 on Lethal Avian Influenza A (H5N1) Virus Infections in Mice

Serum amyloid A (SAA) is an early biomarker of influenza virus disease in BALB/c, C57BL/2, Swiss-Webster, and DBA.2 mice

In vitro activity of favipiravir and neuraminidase inhibitor combinations against oseltamivir-sensitive and oseltamivir-resistant pandemic influenza A (H1N1) virus

Identification of phenanthroindolizines and phenanthroquinolizidines as novel potent anti-coronaviral agents for porcine enteropathogenic coronavirus transmissible gastroenteritis virus and human severe acute respiratory syndrome coronavirus

Design, Synthesis and Antiviral Activity of 2-(3-Amino-4-piperazinylphenyl)chromone Derivatives

Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin

Examining the interactions of Galahad™ compound with viruses to develop a novel inactivated influenza A virus vaccine

Suchergebnisse filtern